Omalizumab Subcutaneous and Trimethobenzamide Capsules
Determining the interaction of Omalizumab Subcutaneous and Trimethobenzamide Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: trimethobenzamide
Brand name: Benzacot, Ticon, Tigan
Synonyms: Trimethobenzamide (oral/injection), Trimethobenzamide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Trimethobenzamide Hydrochloride
- Omalizumab Subcutaneous-Trimethobenzamide Injection Solution
- Omalizumab Subcutaneous-Trimethobenzamide Intramuscular
- Omalizumab Subcutaneous-Trimethobenzamide oral/injection
- Omalizumab Subcutaneous-Trimethoprim
- Omalizumab Subcutaneous-Trimethoprim Oral Solution
- Trimethobenzamide Capsules-Ombitasvir, Paritaprevir, and Ritonavir
- Trimethobenzamide Capsules-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Trimethobenzamide Capsules-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Trimethobenzamide Capsules-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Trimethobenzamide Capsules-Omeclamox-Pak
- Trimethobenzamide Capsules-Omega-3 Fatty Acid Capsules